Silvia Bilia
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Adult-onset Still's disease: analysis of a monocentric cohort of patients.
Journal: Scandinavian journal of rheumatology
Published: May 02, 2024
Efficacy and safety of omalizumab therapy in urticaria vasculitis.
Journal: Frontiers in allergy
Published: May 24, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies.
Journal: Current pharmaceutical design
Published: January 21, 2022
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases.
Journal: Annals of the rheumatic diseases
Published: September 27, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments.
Journal: Current pharmaceutical design
Published: July 01, 2021
One year in review 2021: pathogenesis of rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: May 04, 2021
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study.
Journal: The Lancet. Rheumatology
Published: February 01, 2021
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Journal: Clinical rheumatology
Published: May 26, 2020
Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
Journal: Clinical and experimental rheumatology
Published: April 22, 2020
One year in review 2020: pathogenesis of rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: March 18, 2020
Selexipag may be effective in inducing digital ulcers healing in patients with systemic sclerosis.
Journal: Clinical and experimental rheumatology
Published: March 05, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026